2022
DOI: 10.3389/fimmu.2022.967356
|View full text |Cite
|
Sign up to set email alerts
|

Single-nucleus RNA sequencing reveals the shared mechanisms inducing cognitive impairment between COVID-19 and Alzheimer’s disease

Abstract: Alzheimer’s disease (AD)-like cognitive impairment, a kind of Neuro-COVID syndrome, is a reported complication of SARS-CoV-2 infection. However, the specific mechanisms remain largely unknown. Here, we integrated single-nucleus RNA-sequencing data to explore the potential shared genes and pathways that may lead to cognitive dysfunction in AD and COVID-19. We also constructed ingenuity AD-high-risk scores based on AD-high-risk genes from transcriptomic, proteomic, and Genome-Wide Association Studies (GWAS) data… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
9
0
1

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 15 publications
(11 citation statements)
references
References 54 publications
1
9
0
1
Order By: Relevance
“…There is no debate that post-COVID-19 patients can develop a persistent spectrum of cognitive disturbances ( 7 ), which some authors liken to an Alzheimer’s Disease (AD)-type cognitive impairment ( 39 ). In fact, recent studies have pointed out several neuropathological similarities of PASC Cognitive Syndrome with AD ( 26 ); including, numerous elevated AD marker genes (e.g., FERMT2, HLA-DRB1, GNA15, STAB1, ICA1L, COLGALT1, TNFAIP2, ITGAM, VASP, IDLIA, PVR, TECPR1) ( 39 ), several circulatory biomarkers (i.e. GFAP, NFL, P-tau 181, UCH, NSE, and S100B) ( 26 ), and the presence of Apolipoprotein E ϵ4 allele (APOE4) ( 40 , 41 ), consistent with other reports ( 6 ).…”
Section: Discussionmentioning
confidence: 99%
“…There is no debate that post-COVID-19 patients can develop a persistent spectrum of cognitive disturbances ( 7 ), which some authors liken to an Alzheimer’s Disease (AD)-type cognitive impairment ( 39 ). In fact, recent studies have pointed out several neuropathological similarities of PASC Cognitive Syndrome with AD ( 26 ); including, numerous elevated AD marker genes (e.g., FERMT2, HLA-DRB1, GNA15, STAB1, ICA1L, COLGALT1, TNFAIP2, ITGAM, VASP, IDLIA, PVR, TECPR1) ( 39 ), several circulatory biomarkers (i.e. GFAP, NFL, P-tau 181, UCH, NSE, and S100B) ( 26 ), and the presence of Apolipoprotein E ϵ4 allele (APOE4) ( 40 , 41 ), consistent with other reports ( 6 ).…”
Section: Discussionmentioning
confidence: 99%
“…Researchers have identified significant similarities in neuronal damage, synaptic dysfunction, and neuroinflammation in both diseases. They presented the role of neural cell adhesion molecule 2 (NCAM2) and ICA1L (AD gene marker) in the process leading to cognitive impairment, which may be a potential target for AD intervention (Fu et al, 2022 ).…”
Section: Discussionmentioning
confidence: 99%
“…FindNeighbors and FindCluster were subsequently applied to obtain cell clusters. Next, the single-cell dataset was annotated with known cell markers [24] . To further identify specific subpopulations of plasma cells in UC patients, the plasma cells were redimensionalized and reclustered.…”
Section: Methodsmentioning
confidence: 99%